全球脊椎非固定裝置市場類型、應用、地區及預測

脊椎非固定器材市場規模及預測

2024 年脊椎非固定裝置市場規模價值為 40.8 億美元，預計到 2032 年將達到 56.8 億美元，2026 年至 2032 年的複合年成長率為 4.24%。

脊椎非融合裝置是用於治療各種無需融合脊椎骨節段的脊椎疾病的醫療器材。與將兩個或多個脊椎骨融合在一起以固定脊椎的融合手術不同，脊椎非融合裝置旨在在治療退化性椎間盤疾病、脊椎狹窄和其他脊椎疾病的同時，保持脊椎的運動和靈活性。

由於脊椎狹窄和退化性椎間盤疾病等脊椎疾病的發生率不斷增加，脊椎非融合裝置的市場正在擴大。

脊椎移植用於穩定和激活患者的脊柱，並糾正脊柱失衡。這些裝置通常分為脊椎融合裝置和脊椎非固定裝置。將非固定技術融入脊柱外科手術，使患者能夠活動和伸展脊椎，從而改善了治療效果。

據世界衛生組織稱，腰痛影響著從兒童到​​老年人的各個年齡層，是就醫的常見原因。腰痛的發生率難以估計，因為成年後它已非常常見，而且很可能反覆發作。預計特異性（全身性）腰痛會在工業國家中影響60%至70%的人口在其一生中的某個階段。

脊椎非固定器材的全球市場動態

影響全球脊椎非固定裝置市場的關鍵市場動態是：

主要市場促進因素：

微創手術 (MIS) 的需求日益成長：與標準開放性手術相比，MIS 技術切口較小、失血量更少、恢復時間更快、不適感更少。非固定脊椎固定通常非常適合 MIS 手術，因此對外科醫生和患者都具有吸引力。

人口老化日益加劇：世界人口正在老化，老年人越老，就越容易患上退化性椎間盤疾病和脊椎狹窄等脊椎疾病。這些問題會導致疼痛、僵硬和活動能力下降。脊椎非固定裝置可以幫助緩解症狀，並保持老年人的活動能力。

關注療效和生活品質：患者報告的療效和生活品質指標在醫療保健領域日益重要。非固定脊椎裝置旨在透過緩解疼痛和功能障礙，以及維持脊椎運動和功能，來維持或改善患者的整體生活品質。

微創方法：許多非融合手術可採用微創技術進行，其優點包括切口小、出血量少、恢復時間短。隨著微創手術越來越普及，用於此類手術的脊椎非融合器械的需求也日益成長。

主要挑戰

外科醫師的訓練和應用：非融合脊椎器械通常需要專業的訓練和技能才能正確植入。如果外科醫師不熟悉手術技術或認為學習難度較高，他們可能會猶豫是否使用這些器械。改善外科醫師的教育和培訓計畫可以解決這個問題，並擴大非融合脊椎器械的應用。

長期臨床證據：脊椎非融合裝置的臨床研究已顯示出正面成果，但仍需更多有關其安全性、有效性和耐用性的長期數據。長期臨床數據對於獲得監管部門批准、確保報銷以及增強患者和醫療服務提供者對這些技術長期益處的信心至關重要。

監管挑戰：非固定醫療設備的監管流程複雜且漫長，這可能會延遲新設備的開發和商業化。

主要趨勢：

老年人口不斷成長：隨著世界人口老化，越來越多人可能患上脊椎疾病的人。對於無法承受大型手術風險的長者來說，非固定器械或許是適當的選擇。

注重療效和成本效益：全球醫療保健系統日益注重提供基於價值的醫療服務並降低醫療成本。非融合脊椎器械相比標準融合手術，可望改善臨床療效並降低成本，尤其體現在縮短住院時間、降低再手術率以及提高患者長期滿意度。

脊椎疾病認知度不斷提升：人們對脊椎狹窄症和退化性椎間盤疾病等脊椎疾病的認知度不斷提升。這導致越來越多的人尋求此類疾病的治療，從而推動了對非固定脊椎治療設備的需求。

更重視運動保留：脊椎融合手術可能會減少患者的活動範圍。非固定裝置旨在保留脊椎運動，可能改善患者的長期療效。

目錄

第1章：全球脊椎非固定器材市場簡介

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章 脊椎非固定器材的全球市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

5. 全球脊椎非固定裝置市場（依應用）

• 概述
• 醫院

6. 全球脊椎非固定裝置市場（按類型）

• 概述
• 人工全人工椎間盤置換術
• 動態穩定化裝置
• 環形修復裝置

7. 全球脊椎非固定器材市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 拉丁美洲
  • 中東和非洲

8. 全球脊椎非固定裝置市場的競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第9章 公司簡介

• Centinel Spine, LLC
• B. Braun Melsungen
• Johnson & Johnson
• Medtronic PLC
• Pioneer Surgical Technologies
• Synthes Holding AG
• Depuy Spine
• Globus Medical Inc.
• NuVasive, Inc.
• Zimmer Biomet

第10章 重大進展

• 產品發布/開發
• 合併與收購
• 業務擴展
• 夥伴關係與合作

第11章 附錄

• 相關調查

Non-fusion Spinal Devices Market Size And Forecast

Non-fusion Spinal Devices Market size was valued at USD 4.08 Billion in 2024 and is projected to reach USD 5.68 Billion by 2032, growing at a CAGR of 4.24% from 2026 to 2032.

Non-fusion spinal devices are medical devices used to treat a variety of spine diseases that do not require vertebral segment fusion. Unlike fusion operations, which join two or more vertebrae together to immobilize the spine, non-fusion devices aim to maintain motion and flexibility in the spine while treating degenerative disc disease, spinal stenosis, and other spinal conditions.

The non-fusion spinal devices market is expanding due to the increasing frequency of spinal illnesses such as spinal stenosis and degenerative disc disease.

Spinal implants are used to stabilize and revitalize patients' spines, as well as to right spinal disproportions. These devices are generically categorized as fusion or non-fusion spinal devices. Integrating non-fusion technologies into spinal surgery has improved outcomes by allowing patients to move and stretch their spines.

According to the WHO, back pain affects everyone, regardless of age, from children to the elderly, and is a common reason for medical visits. It is difficult to estimate the incidence of back pain because it is already extremely common by the time a person reaches adulthood, and the symptoms are likely to repeat throughout time. Non-specific (common) back pain is expected to affect 60% to 70% of people in industrialized countries over their lifespan.

Global Non-fusion Spinal Devices Market Dynamics

The key market dynamics that are shaping the global non-fusion spinal device market include:

Key Market Drivers:

Increasing Demand for Minimally Invasive Surgery (MIS) Treatments: MIS techniques are associated with smaller incisions, less blood loss, faster recovery times, and less discomfort than standard open operations. Non-fusion spinal devices are frequently well-suited for MIS treatments, boosting their appeal to both surgeons and patients.

Expanding Aging Population: The global population is aging, and as people get older, they are more susceptible to developing spine diseases such as degenerative disc degeneration and spinal stenosis. These problems can lead to pain, stiffness, and trouble moving. Non-fusion spinal devices can help relieve symptoms and maintain mobility in older persons.

Focus on Outcomes and Quality of Life: Patient-reported outcomes and quality of life metrics are becoming increasingly important in healthcare. Non-fusion spinal devices are intended not just to relieve pain and dysfunction, but also to maintain or improve patients' overall quality of life by maintaining spinal motion and function.

Minimally Invasive Approaches: Many non-fusion operations can be performed with minimally invasive techniques, which have advantages such as smaller incisions, less blood loss, and faster recovery times. As minimally invasive procedures become increasingly popular, there is a greater demand for non-fusion spinal devices that work with these techniques.

Key Challenges:

Surgeon Training and Adoption: Non-fusion spinal devices frequently necessitate specialized training and skill to properly implant. Surgeons may be hesitant to use these devices if they are unfamiliar with the surgical techniques or see a steep learning curve. Improving surgeon education and training programs can help to address this issue and enable greater utilization of non-fusion spinal devices.

Long-Term Clinical Evidence: While clinical studies on non-fusion spinal devices have provided positive results, more long-term data on their safety, efficacy, and durability are required. Long-term clinical data is critical for obtaining regulatory clearance, securing payment, and instilling patient and healthcare provider confidence in these technologies' long-term advantages.

Regulatory Challenges: The regulation process for non-fusion devices can be complicated and time-consuming. This might cause delays in the development and commercialization of new devices.

Key Trends:

Growing Geriatric Population: As the world's population ages, more people are likely to have spine disorders. Non-fusion devices may be an appropriate choice for older individuals who are unable to fight the risks involved with major surgery.

Focus on Outcomes and Cost-Effectiveness: Healthcare systems around the world are increasingly focused on providing value-based care and reducing healthcare costs. Non-fusion spinal devices have the potential to improve clinical outcomes and cost savings over standard fusion surgeries, particularly in terms of shorter hospital stays, lower rates of revision surgery, and better long-term patient satisfaction.

Growing Awareness of Spinal Disorders: There is a growing awareness of spinal disorders, such as spinal stenosis and disc degeneration. This is leading to more people seeking treatment for these conditions, which is driving up the demand for non-fusion spinal devices.

Increasing Focus on Motion Preservation: Spinal fusion surgery might reduce a patient's range of motion. Non-fusion devices aim to maintain motion in the spine, which can result in better long-term outcomes for patients.

Global Non-fusion Spinal Devices Market Regional Analysis

Here is a more detailed regional analysis of the global non-fusion spinal device market:

North America:

The benefits of non-fusion spinal devices corresponds in North America have seen a quick adoption of modern medical technology, particularly non-fusion spinal devices, because of variables such as high healthcare spending, a robust research and development infrastructure, and a strong demand for new treatment choices. Patients and healthcare providers in the region are increasingly embracing minimally invasive procedures that enable quicker recovery periods and better outcomes.

Government activities and policies in North America have contributed significantly to the introduction of non-fusion spinal devices. Efforts to improve the quality of life for people suffering from spinal problems have resulted in increasing funding for R&D and healthcare infrastructure. Furthermore, regulatory authorities such as the FDA in the United States have simplified the approval procedure for these devices, enabling fast market access and encouraging innovation in the industry.

Overall, a favorable regulatory environment, innovations in technology, and government assistance have pushed North America to the forefront of the spinal non-fusion device market. As the region continues to prioritize healthcare innovation and quality improvement measures, its dominance in this industry is projected to last for the foreseeable future.

Asia Pacific:

The Asia Pacific area offers promising market opportunities for spinal non-fusion devices, due to factors such as rising awareness of healthy living, growth of medical facilities, and a significant increase in elderly people. With an increasing emphasis on preventative healthcare and greater access to medical services throughout the region, people are becoming more aware of the necessity of preserving spinal health. This increased knowledge, combined with a rise in healthcare infrastructure development, presents a favorable climate for the adoption of innovative spinal treatment options, such as non-fusion devices.

Furthermore, the Asia Pacific region is undergoing a large demographic shift, with a substantial increase in aged people. According to the United Nations Economic and Social Commission for Asia and the Pacific demographic statistics sheet from 2016, 12.4% of the region's population was 60 years or older, a proportion that is anticipated to rise even higher by 2050.

This demographic trend highlights the increased demand for innovative solutions to age-related spinal disorders, which is driving the regional non-fusion spinal device market. As Asia Pacific's healthcare systems modernize and focus on meeting the demands of an aging population, the market for spinal non-fusion devices is expected to rise significantly.

Global Non-fusion Spinal Device Market: Segmentation Analysis

The Global Non-fusion Spinal Device Market is Segmented on the basis of Type, Application, And Geography.

Non-fusion Spinal Device Market, By Type

• Artificial Discs Replacement
• Dynamic Stabilization Devices
• Annulus Repair Devices

Based on the Component, the market is bifurcated into Artificial Discs Replacement, Dynamic Stabilization Devices and Annulus Repair Devices. Growing markets in the non-fusion spinal device sector. It's difficult to say for certain which is growing the fastest, but annulus repair devices are a relatively new technology that may be enjoying the fastest growth due to an increased emphasis on motion preservation methodologies.

Non-fusion Spinal Device Market, By Application

• Hospitals
• Ambulatory Surgical Centers

Based on Application, the market is segmented into Hospitals and Ambulatory Surgical Centers. However, Ambulatory Surgical Centers are predicted to increase quicker due to the growing preference for minimally invasive treatments and outpatient care. These operations are less expensive and require shorter recovery times, making ASCs a more appealing alternative for both patients and insurance.

Non-fusion Spinal Device Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Non-fusion Spinal Device Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share of non-fusion spinal device followed by Europe. Growing demand for effective emergency care and increasing adoption of mobile surgery centers are anticipated to drive the industry during the forecast period.

Key Players

The "Global Non-fusion Spinal Device Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Centinel Spine, LLC, B. Braun Melsungen, Johnson & Johnson, Medtronic PLC, Pioneer Surgical Technologies, Synthes Holding AG, Depuy Spine, Globus Medical Inc., and NuVasive, Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Non-fusion Spinal Device Market Recent Developments
• In June 2024, Premia Spine got FDA approval for its Total Posterior Spine (TOPS) facet joint replacement system. The TOPS System previously received the FDA's Breakthrough Designation and has now successfully completed its Premarket Approval (PMA) application. The TOPS(TM) System replaces anatomical elements destroyed during spinal decompression treatment, such as the lamina and facet joint, to relieve pain.
• In November 2022, Spinal Stabilization Technologies Ltd announced that it has begun the LOPAIN2 clinical trial to assess the effectiveness of the PerQdisc Nucleus Replacement Device (NRD). The trial is expected to take place in South America, with 72 patients participating.
• In August 2021, Orthofix US LLC announced the first patient implant in the M6-C Artificial Cervical Disc 2-Level Investigation Device Exemption (IDE) Study. The FDA authorized the M6-C artificial cervical disc in 2019 for single-level implantation from C3 to C7 as an alternative to cervical fusion.
• In April 2021, NuVasive Inc received 510k approval from the US FDA for the use of Simplify Disc, a two-level cervical complete disc replacement.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NON-FUSION SPINAL DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NON-FUSION SPINAL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NON-FUSION SPINAL DEVICES MARKET, BY APPLICATION

• 5.1 Overview
• 5.2 Hospitals

6 GLOBAL NON-FUSION SPINAL DEVICES MARKET, BY TYPE

• 6.1 Overview
• 6.2 Artificial Discs Replacement
• 6.3 Dynamic Stabilization Devices
• 6.4 Annulus Repair Devices

7 GLOBAL NON-FUSION SPINAL DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NON-FUSION SPINAL DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Centinel Spine, LLC
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 B. Braun Melsungen
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Johnson & Johnson
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Medtronic PLC
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Pioneer Surgical Technologies
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Synthes Holding AG
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Depuy Spine
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Globus Medical Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 NuVasive, Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Zimmer Biomet
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research